Navigation Links
Express Scripts Reports First Quarter EPS of $0.86, up 23%
Date:4/29/2009

ed Selected Information (in millions) 3 Months Ended March 31, ------------ Claims Volume 2009 2008 ---- ---- Network 94.2 98.2 Home Delivery & Specialty 9.9 10.4 Other (1) 0.8 0.8 --- --- Total claims 104.9 109.4 ----- ----- Total adjusted claims (2) 124.1 129.6 ===== ===== Depreciation and Amortization (D&A): Gross profit D&A $6.4 $7.0 Selling, general & administrative D&A 18.2 17.5 ---- ---- Total D&A $24.6 $24.5 ==== ==== Generic Fill Rate Network 69.0% 66.4% Home Delivery 56.9% 53.9% Overall 67.7% 65.1% (1) Other claims represent: (a) drugs distributed through patient assistance programs (b) drugs distributed where we have been selected by the pharmaceutical manufacturer as part of a limited distribution network and (c) Emerging Market claims. (2) Total adjusted claims reflect home delivery claims multiplied by 3, as home delivery claims are typically 90 day claims. Table 2 EBITDA Reconciliation (in millions, except per claim data) The following is a reconciliation of net income from continuing opera
'/>"/>
SOURCE Express Scripts, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. General Public and Physicians Express Similar Levels of Concern Regarding Potential Swine Flu Pandemic
2. Express Scripts Pharmacy Cost Trends Lowest in Over a Decade
3. ExpressMD(TM) Solutions Remote Patient Health Monitoring Device Receives 510(K) Market Clearance Approval From FDA
4. While the Majority of Americans Express Interest in Organ and Tissue Donation, Too Few Take Steps to Register as Donors
5. While majority of Americans express interest in organ and tissue donation, few register
6. Nick Jonas and Bayer Diabetes Care Launch Creativity Contest to Encourage Kids With Diabetes to Express Their Simple Win
7. Express Scripts Announces Definitive Agreement to Acquire WellPoint NextRx Subsidiaries for $4.675 Billion
8. Golub Capital Provides Debt Financing to Support the Acquisition of Network Express, Inc., by Ace Expediters, Inc.
9. Lowes Leads First Wave of Companies Partnering With Express Scripts to Apply Behavioral Economics to Healthcare
10. Confidential Listening Service We Just Listen Launches, Providing Americans a Private Platform to Express Their Thoughts and Feelings
11. Expresso Fitness(R) Launches First Virtual Reality Cardio Bike for Kids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Women over the age of 65 face numerous barriers ... struggles against poverty and higher rates of asthma with ... issue of Annals of Allergy, Asthma and Immunology ... Allergy, Asthma and Immunology (ACAAI), outlines the challenges faced ... solutions to improve their care. , "Allergists ...
(Date:7/31/2014)... 2014 The 2013 PolyU TSI ... points from 75.07 in 2012. The index measures ... and integrates them into an overall index. The ... more satisfied with Hong Kong over time. , ... in service performance in Hong Kong are attractions ...
(Date:7/31/2014)... 2014 Ce-Classes.com has announced that they ... healthcare professionals, a Systematic Review of Sexual Satisfaction ... in the International Journal of Clinical and Health Psychology. ... to a need to have accurate information about sexual ... treatment possible. The material provides a systematic review ...
(Date:7/31/2014)... GA (PRWEB) July 31, 2014 In today’s ... increasingly difficult to get. Snoring and sleep apnea (a medical ... rob people and their bed partners of the rest they ... 45% of the population snores and 20 million people in ... 10% have been diagnosed and treated; and of those treated, ...
(Date:7/31/2014)... Weblify has finally been released by marketing and advertising ... The result is a perfected and fine tuned platform ... minutes without knowing any HTML or other programming languages. , ... SEO expert, agrees that this platform allows anyone to create ... web site builders out there, but this is truly unique. ...
Breaking Medicine News(10 mins):Health News:Female baby boomers with asthma? You may need help 2Health News:Female baby boomers with asthma? You may need help 3Health News:PolyU Released Report On 2013 Tourist Satisfaction and Tourism Service Quality Indices to Boost Tourism Development 2Health News:PolyU Released Report On 2013 Tourist Satisfaction and Tourism Service Quality Indices to Boost Tourism Development 3Health News:Company Provides New Course on Sexual Satisfaction 2Health News:Company Provides New Course on Sexual Satisfaction 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 2Health News:Weblify Review Exposes Ricky Mataka And His New Site Building Platform 3
... , WEDNESDAY, Oct. 13 (HealthDay News) -- Hispanics in the ... by almost eight years, according to a new report. ... Control and Prevention on Wednesday, confirms the so-called "Hispanic paradox" ... live longer than others. "We have known ...
... 2010 Nutrition rating systems and symbols on the ... shoppers if they highlighted four nutrients of greatest concern ... says a new report from the Institute of Medicine. ... most strongly with diet-related health problems affecting many Americans, ...
... (DBS) has proven to be a lifeline for some ... that can cause lack of control over movement, poor ... The procedure is used only for patients ... neurosurgeon uses magnetic resonance imaging or computed tomography to ...
... experience changes in sexual function that leave them feeling ... at the 35th Congress of the European Society for ... that these sexuality and fertility concerns are often not ... from Flinders Medical Centre in Adelaide said that fertility ...
... J. Marc Overhage, M.D., Ph.D., a national leader in ... health information exchange, has been elected to the prestigious ... Dr. Overhage is at the forefront of ... and exchange of medical data to improve patient care ...
... (XMRV) has been the subject of many studies since ... an unclear picture of XMRV,s role in human disease. ... issue of The Journal of Infectious Diseases , ... between XMRV and prostate cancer but not other links ...
Cached Medicine News:Health News:U.S. Hispanics Outlive General Population: CDC 2Health News:U.S. Hispanics Outlive General Population: CDC 3Health News:Nutrition rating enhancing front-of-package nutrition rating systems and symbols: Phase 1 2Health News:Researchers reach consensus on use of deep brain stimulation to treat Parkinson's 2Health News:Fertility concerns of cancer survivors inadequately addressed, study finds 2Health News:Fertility concerns of cancer survivors inadequately addressed, study finds 3Health News:J. Marc Overhage elected to Institute of Medicine 2Health News:New studies examine links between XMRV and human disease 2Health News:New studies examine links between XMRV and human disease 3
(Date:7/31/2014)... , July 31, 2014 Catylix, Inc. ... Scientific ( Milpitas, California ) announced ... develop and commercialize new fluorination products and related ... has benefited from the use of substituents that ... lipophilicity with polarity to improve binding and bioavailability. ...
(Date:7/31/2014)... the list of stocks featured in the Analyst Blog. Every ... and events impacting stocks and the financial markets. Stocks recently ... Free Report ), Gilead (Nasdaq: GILD - Free Report ... AbbVie (NYSE: ABBV - Free Report ) and Celgene ... Zacks is promoting its ,Buy, stock recommendations. Get #1Stock ...
(Date:7/31/2014)... Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company ... conference call on Thursday, August 14, 2014, at 4:30 p.m. ... June 30, 2014. Financial results will be issued in a ... President and CEO James LaFrance will host the ... Date: Thursday, August 14, 2014 Time: 4:30 p.m. Eastern time ...
Breaking Medicine Technology:Catylix, Inc. and Aspira Scientific Announce Joint Venture to Commercialize New Fluorination Technologies 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 2
... Minn., May 1, 2012  Angeion Corporation (NASDAQ: ... Margolies as Executive Vice President – Global Sales effective ... leading all aspects of the company,s worldwide sales organization ... goals consistent with Angeion,s corporate strategy.  Mr. Margolies will ...
... Total quarterly revenues of $691 million, increased 23 percent versus ... Qualitest revenue growth of 8 percent.  , ... , Reported quarterly diluted loss per share ... , Management expects return to year-over-year adjusted diluted ...
Cached Medicine Technology:Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales 2Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales 3Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales 4Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel 2Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel 3Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel 4Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel 5Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel 6Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel 7Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel 8Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel 9Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel 10Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel 11Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel 12Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel 13Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel 14Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel 15
... of infectious disease ELISA products make us ... assay protocols for faster integration into the ... provide increased reliability and run-to-run consistency. Our ... assays for a wide range of serological ...
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
... We offer a complete line ... laboratorians state-of-the-art monoclonal and monoclonal/polyclonal ... detection of enteric pathogens in ... products for Clostridium difficile, Entamoeba ...
... Tox A/B II is a second-generation rapid ELISA ... and B in fecal specimens. The test utilizes ... detecting not only the more common toxin A+ ... It's easy to perform, produces no indeterminates and ...
Medicine Products: